Concepedia

Mark Hatherill

MH

Statistics

Publications

164

Citations

15.1K

H-Index

63

Active since

1997

Affiliations

University of Cape Town(Current)

South African Tuberculosis Vaccine Initiative

Stellenbosch University

South African Medical Research Council

Mark Hatherill is an author at University of Cape Town specializing in infectious diseases, immunology, and tuberculosis vaccination.

Publications per year

1997–2025

164

Publications

164

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

Public Health, Immunology, Pediatrics +14

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

Daniel E. Zak, Adam Penn‐Nicholson, Thomas J. Scriba et al. · The Lancet · 2016 · 817 citations · Full text

Public Health, Immunology, Infectious Diseases +16

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 667 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 595 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 444 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 164